Active, Not Recruiting
Study of Pembrolizumab Combined With Decitabine and Pralatrexate in PTCL and CTCL
NCT03240211
- Conditions
- CTCL, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Allegheny Health Network Pittsburgh, Pennsylvania, United States
- University of Virginia Charlottesville, Virginia, United States